Stock listing
A2PLU4 Stock Price, News, Filings & Events — Capricor Therapeutics, Inc.
Selected listing: A2PLU4 · LS · EUR · DE
This page tracks Capricor Therapeutics, Inc.'s A2PLU4:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2PLU4:LS. A2PLU4:LS is the stock-level entry point for investors researching Capricor Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A2PLU4:LS
- Asset type
- Stock
- Market cap
- $557.6M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LS
- Currency
- EUR
Capricor Therapeutics, Inc. A2PLU4:LS stock context
This page tracks Capricor Therapeutics, Inc.'s A2PLU4:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2PLU4:LS. A2PLU4:LS is the stock-level entry point for investors researching Capricor Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Capricor Therapeutics, Inc.
Capricor Therapeutics Announces Extension of PDUFA Target Action Date as FDA Continues Review of Deramiocel BLA
August 24, 2026
Capricor Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
August 13, 2026
Capricor Therapeutics Provides Update on FDA Advisory Committee Meeting for Deramiocel
July 30, 2026
The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy
July 29, 2026
Capricor Therapeutics Announces FDA Advisory Committee Meeting to Review BLA for Deramiocel for the Treatment of Duchenne Muscular Dystrophy
June 26, 2026
Capricor Therapeutics, Inc. earnings calls
Capricor Therapeutics, Inc. (CAPR) Q2 2026 Earnings Call
August 13, 2026 · Replay with transcript and chapters
Capricor Therapeutics, Inc. (CAPR) Q1 2026 Earnings Call
May 12, 2026 · Replay with transcript and chapters
Capricor Therapeutics, Inc. (CAPR) Q4 2025 Earnings Call
March 12, 2026 · Replay with transcript and chapters
Capricor Therapeutics, Inc. (CAPR) Q3 2025 Earnings Call
November 10, 2025 · Replay with transcript and chapters
Capricor Therapeutics, Inc. (CAPR) Q2 2025 Earnings Call
August 13, 2025 · Replay with transcript and chapters
Capricor Therapeutics, Inc. (CAPR) Q1 2025 Earnings Call
May 13, 2025 · Replay with transcript and chapters
Research Capricor Therapeutics, Inc.
Capricor Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for A2PLU4:LS.
Capricor Therapeutics, Inc. company profile
View the public company page for Capricor Therapeutics, Inc. on 6ix.
Capricor Therapeutics, Inc. news
Read company news and market updates connected to Capricor Therapeutics, Inc..
Capricor Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Capricor Therapeutics, Inc..
Alternate listings
CAPR:NASDAQ
US · USD
Alternate listing for Capricor Therapeutics, Inc.; the primary context on this page is A2PLU4:LS.
4LN2:GETTEX
DE · EUR
Alternate listing for Capricor Therapeutics, Inc.; the primary context on this page is A2PLU4:LS.
4LN2:TRADEGATE
DE · EUR
Alternate listing for Capricor Therapeutics, Inc.; the primary context on this page is A2PLU4:LS.
A2PLU4:LSX
DE · EUR
Alternate listing for Capricor Therapeutics, Inc.; the primary context on this page is A2PLU4:LS.
CAPR:BOATS
US · USD
Alternate listing for Capricor Therapeutics, Inc.; the primary context on this page is A2PLU4:LS.
4LN2:DUS
DE · EUR
Alternate listing for Capricor Therapeutics, Inc.; the primary context on this page is A2PLU4:LS.
4LN2:FWB
DE · EUR
Alternate listing for Capricor Therapeutics, Inc.; the primary context on this page is A2PLU4:LS.
4LN2:SWB
DE · EUR
Alternate listing for Capricor Therapeutics, Inc.; the primary context on this page is A2PLU4:LS.